PEPT Among Its Peers
End-of-day Nov 12, 2026 · 0 ETFs by YTD
Loading…
Getting the latest data.
Rexshares[…]
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | Max |
|---|---|---|---|---|---|---|---|---|---|
| Total return | −0.7% | +2.8% | +10.6% | — | — | — | — | — | +10.6% |
| S&P 500 · VOO | −0.3% | +3.3% | −1.6% | −2.2% | +11.9% | +12.1% | +80.1% | +73.9% | — |
$136 of every $1,000 in PEPT is Eli
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | LLYELI Lilly | Healthcare | 13.56% | $1,356.26 | 315 | $453K |
| 2 | ASNDAscendis Pharma A/S | Healthcare | 10.61% | $1,060.98 | 1,366 | $354K |
| 3 | NVONovo Nordisk A/S | Healthcare | 9.99% | $999.00 | 8,116 | $333K |
| 4 | PODDInsulet | Healthcare | 7.90% | $790.10 | 1,758 | $264K |
| 5 | PTGXProtagonist Therapeutics | Healthcare | 6.30% | $630.22 | 1,560 | $210K |
| 6 | SANSanofi | Financial Services | 5.80% | $580.11 | 2,015 | $194K |
| 7 | RYTMRhythm Pharmaceuticals | Healthcare | 5.66% | $566.48 | 1,686 | $189K |
| 8 | DARDarling Ingredients | Consumer Defensive | 3.97% | $397.48 | 2,449 | $133K |
| 9 | VKTXViking Therapeutics | Healthcare | 3.81% | $381.08 | 4,473 | $127K |
| 10 | —Bachem | — | 3.57% | $357.10 | 1,228 | $119K |
| 11 | —Ipsen | — | 2.99% | $299.19 | 538 | $100K |
| 12 | PBLSParabilis Medicines | Healthcare | 2.72% | $272.32 | 3,066 | $91K |
| 13 | ZEALZealand Pharma A/S | — | 2.72% | $272.14 | 2,497 | $91K |
| 14 | AUPHAurinia Pharmaceuticals | Healthcare | 2.27% | $226.87 | 4,672 | $76K |
| 15 | NEUNeuren Pharmaceuticals | Basic Materials | 2.13% | $212.75 | 4,326 | $71K |
PEPT has no close peers in our data yet: […]
Not enough history yet: PEPT needs a year of prices.
PEPT does not pay a distribution.
Official documents are being connected from SEC EDGAR: […]. Read the issuer’s prospectus before investing.
Estimated yearly cost excludes trading costs and assumes constant assets.
No payouts on record: […]
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | LLY | ELI Lilly & | 13.56% |
| 2 | ASND | Ascendis Pharma A/S | 10.61% |
| 3 | NVO | Novo Nordisk A/S | 9.99% |
| 4 | PODD | Insulet | 7.90% |
| 5 | PTGX | Protagonist Therapeutics | 6.30% |
| 6 | SAN | Sanofi | 5.80% |
| 7 | RYTM | Rhythm Pharmaceuticals | 5.66% |
| 8 | DAR | Darling Ingredients | 3.97% |
| 9 | VKTX | Viking Therapeutics | 3.81% |
| 10 | PBLS | Parabilis Medicines | 2.72% |